心房动:从致病源到新的治疗选择
Yi Liu1, Yuwei Chen1, Qiang Ren1
1Department of Cardiology Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China.
Molecular biomedicine
|December 19, 2025
概括
脉冲场切除 (PFA) 为心房动 (AF) 管理提供了一种比传统热切除更安全的替代方案. 本综述探讨了PFA和其他针对个性化AF治疗的创新.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗技术 医疗技术 医学技术
背景情况:
- 目前的心房动 (AF) 管理面临的安全性和耐久性的局限性.
- 了解AF病理生理学,从触发器到纤维化重塑,对于开发新疗法至关重要.
研究的目的:
- 提供关于不断变化的AF管理策略的全面更新.
- 批判性地评估新的诊断和治疗创新,重点是脉冲场切除 (PFA).
主要方法:
- 系统性审查将AF病原体机制与新兴创新联系起来.
- 脉冲场切除 (PFA),高分辨率电解剖学绘图,混合策略和药理干预的评估.
- 综合了最近关于程序工作流程和有效性的随机试验数据.
主要成果:
- 脉冲场切除 (PFA) 证明了基于不可逆转的电穿孔的优越心肌选择性安全概况.
- 绘图和混合方法的进步为耐火病例提供了改进的基质表征和治疗.
- 来自试验的新出现的数据突出显示了疗效,但在损伤耐久性和非肺静脉驱动器管理方面也存在持续的挑战.
结论:
- 提出了一个以表型为指导的管理框架,以优化对新兴AF技术的患者选择.
- 未来的研究应该专注于新型AF治疗的长期比较有效性.
- 目标是为心房动患者实现更安全,更持久和个性化的节律控制.
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
411
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
411
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
421
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
421
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Disturbances in Heart Rhythm
2.4K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
325
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
325


